Therapeutic vaccination for treatment of chronic hepatitis B
Autor: | Eleanor Barnes, Tamsin Cargill |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Hepatitis B virus medicine.medical_treatment Immunology Reviews Review Disease 03 medical and health sciences Hepatitis B Chronic 0302 clinical medicine Immune system medicine Animals Humans Immunology and Allergy Hepatitis B Vaccines business.industry Vaccination T cell Immunotherapy Hepatitis B medicine.disease Vaccine efficacy digestive system diseases Chronic infection 030104 developmental biology Hepatocellular carcinoma hepatitis B immunotherapy business 030215 immunology |
Zdroj: | Clinical and Experimental Immunology |
ISSN: | 1365-2249 0009-9104 |
DOI: | 10.1111/cei.13614 |
Popis: | Summary Chronic hepatitis B infection remains a serious global health threat, contributing to a large number of deaths through liver cirrhosis and hepatocellular carcinoma. Current treatment does not eradicate disease, and therefore new treatments are urgently needed. In acute hepatitis B virus (HBV) a strong immune response is necessary to clear the virus, but in chronic infection the immune response is weakened and dysfunctional. Therapeutic vaccination describes the process of inoculating individuals with a non‐infective form of viral antigen with the aim of inducing or boosting existing HBV‐specific immune responses, resulting in sustained control of HBV infection. In this review we outline the rationale for therapeutic vaccination in chronic HBV infection, discuss previous and ongoing trials of novel HBV therapeutic vaccine candidates and outline strategies to improve vaccine efficacy going forward. Hepatitis B virus (HBV) is a serious global health threat. Current treatments do not cure the disease. This review summaries the potential of therapeutic vaccination as a strategy to treat chronic HBV infection. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |